nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0556	0.0879	CbGbCtD
Darunavir—CYP3A4—Felbamate—epilepsy syndrome	0.0517	0.0817	CbGbCtD
Darunavir—CYP3A4—Trimethadione—epilepsy syndrome	0.0517	0.0817	CbGbCtD
Darunavir—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0486	0.0768	CbGbCtD
Darunavir—CYP3A4—Clonazepam—epilepsy syndrome	0.0439	0.0695	CbGbCtD
Darunavir—CYP3A4—Clobazam—epilepsy syndrome	0.0421	0.0666	CbGbCtD
Darunavir—CYP3A4—Rufinamide—epilepsy syndrome	0.0358	0.0566	CbGbCtD
Darunavir—CYP3A4—Carbamazepine—epilepsy syndrome	0.0349	0.0552	CbGbCtD
Darunavir—CYP3A4—Primidone—epilepsy syndrome	0.0326	0.0515	CbGbCtD
Darunavir—CYP3A4—Phenytoin—epilepsy syndrome	0.0313	0.0495	CbGbCtD
Darunavir—CYP3A4—Propofol—epilepsy syndrome	0.0292	0.0462	CbGbCtD
Darunavir—CYP3A4—Acetazolamide—epilepsy syndrome	0.0279	0.0441	CbGbCtD
Darunavir—CYP3A4—Phenobarbital—epilepsy syndrome	0.0279	0.0441	CbGbCtD
Darunavir—CYP3A4—Midazolam—epilepsy syndrome	0.0275	0.0435	CbGbCtD
Darunavir—CYP3A4—Diazepam—epilepsy syndrome	0.0264	0.0418	CbGbCtD
Darunavir—CYP3A4—Zonisamide—epilepsy syndrome	0.0258	0.0408	CbGbCtD
Darunavir—CYP3A4—Valproic Acid—epilepsy syndrome	0.0208	0.033	CbGbCtD
Darunavir—CYP3A4—Topiramate—epilepsy syndrome	0.0188	0.0297	CbGbCtD
Darunavir—Amprenavir—CYP2C19—epilepsy syndrome	0.0014	0.44	CrCbGaD
Darunavir—Amprenavir—CYP2D6—epilepsy syndrome	0.00104	0.327	CrCbGaD
Darunavir—Amprenavir—ABCB1—epilepsy syndrome	0.000739	0.233	CrCbGaD
Darunavir—Headache—Vigabatrin—epilepsy syndrome	6.75e-05	0.000185	CcSEcCtD
Darunavir—Hypertension—Pregabalin—epilepsy syndrome	6.75e-05	0.000185	CcSEcCtD
Darunavir—Vomiting—Diazepam—epilepsy syndrome	6.75e-05	0.000185	CcSEcCtD
Darunavir—Anorexia—Valproic Acid—epilepsy syndrome	6.73e-05	0.000185	CcSEcCtD
Darunavir—Rash—Diazepam—epilepsy syndrome	6.69e-05	0.000184	CcSEcCtD
Darunavir—Dermatitis—Diazepam—epilepsy syndrome	6.69e-05	0.000183	CcSEcCtD
Darunavir—Visual impairment—Topiramate—epilepsy syndrome	6.68e-05	0.000183	CcSEcCtD
Darunavir—Myalgia—Pregabalin—epilepsy syndrome	6.65e-05	0.000183	CcSEcCtD
Darunavir—Arthralgia—Pregabalin—epilepsy syndrome	6.65e-05	0.000183	CcSEcCtD
Darunavir—Chest pain—Pregabalin—epilepsy syndrome	6.65e-05	0.000183	CcSEcCtD
Darunavir—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.65e-05	0.000182	CcSEcCtD
Darunavir—Dizziness—Zonisamide—epilepsy syndrome	6.65e-05	0.000182	CcSEcCtD
Darunavir—Headache—Diazepam—epilepsy syndrome	6.65e-05	0.000182	CcSEcCtD
Darunavir—Anxiety—Pregabalin—epilepsy syndrome	6.63e-05	0.000182	CcSEcCtD
Darunavir—Diarrhoea—Clonazepam—epilepsy syndrome	6.63e-05	0.000182	CcSEcCtD
Darunavir—Anaemia—Gabapentin—epilepsy syndrome	6.62e-05	0.000182	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.61e-05	0.000181	CcSEcCtD
Darunavir—Asthenia—Carbamazepine—epilepsy syndrome	6.59e-05	0.000181	CcSEcCtD
Darunavir—Agitation—Gabapentin—epilepsy syndrome	6.59e-05	0.000181	CcSEcCtD
Darunavir—Diarrhoea—Phenytoin—epilepsy syndrome	6.59e-05	0.000181	CcSEcCtD
Darunavir—Discomfort—Pregabalin—epilepsy syndrome	6.58e-05	0.00018	CcSEcCtD
Darunavir—Nausea—Fosphenytoin—epilepsy syndrome	6.57e-05	0.00018	CcSEcCtD
Darunavir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.55e-05	0.00018	CcSEcCtD
Darunavir—Erythema multiforme—Topiramate—epilepsy syndrome	6.55e-05	0.00018	CcSEcCtD
Darunavir—Angioedema—Gabapentin—epilepsy syndrome	6.55e-05	0.00018	CcSEcCtD
Darunavir—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.54e-05	0.000179	CcSEcCtD
Darunavir—Vomiting—Felbamate—epilepsy syndrome	6.53e-05	0.000179	CcSEcCtD
Darunavir—Dry mouth—Pregabalin—epilepsy syndrome	6.51e-05	0.000179	CcSEcCtD
Darunavir—Pruritus—Carbamazepine—epilepsy syndrome	6.5e-05	0.000178	CcSEcCtD
Darunavir—Rash—Felbamate—epilepsy syndrome	6.48e-05	0.000178	CcSEcCtD
Darunavir—Eye disorder—Topiramate—epilepsy syndrome	6.47e-05	0.000178	CcSEcCtD
Darunavir—Dermatitis—Felbamate—epilepsy syndrome	6.47e-05	0.000178	CcSEcCtD
Darunavir—Malaise—Gabapentin—epilepsy syndrome	6.46e-05	0.000177	CcSEcCtD
Darunavir—Vertigo—Gabapentin—epilepsy syndrome	6.44e-05	0.000177	CcSEcCtD
Darunavir—Headache—Felbamate—epilepsy syndrome	6.44e-05	0.000177	CcSEcCtD
Darunavir—Confusional state—Pregabalin—epilepsy syndrome	6.43e-05	0.000176	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.43e-05	0.000176	CcSEcCtD
Darunavir—Cardiac disorder—Topiramate—epilepsy syndrome	6.43e-05	0.000176	CcSEcCtD
Darunavir—Flushing—Topiramate—epilepsy syndrome	6.43e-05	0.000176	CcSEcCtD
Darunavir—Syncope—Gabapentin—epilepsy syndrome	6.43e-05	0.000176	CcSEcCtD
Darunavir—Leukopenia—Gabapentin—epilepsy syndrome	6.42e-05	0.000176	CcSEcCtD
Darunavir—Dizziness—Clonazepam—epilepsy syndrome	6.41e-05	0.000176	CcSEcCtD
Darunavir—Nausea—Vigabatrin—epilepsy syndrome	6.4e-05	0.000176	CcSEcCtD
Darunavir—Vomiting—Zonisamide—epilepsy syndrome	6.39e-05	0.000175	CcSEcCtD
Darunavir—Insomnia—Valproic Acid—epilepsy syndrome	6.38e-05	0.000175	CcSEcCtD
Darunavir—Asthenia—Lamotrigine—epilepsy syndrome	6.37e-05	0.000175	CcSEcCtD
Darunavir—Dizziness—Phenytoin—epilepsy syndrome	6.37e-05	0.000175	CcSEcCtD
Darunavir—Rash—Zonisamide—epilepsy syndrome	6.34e-05	0.000174	CcSEcCtD
Darunavir—Paraesthesia—Valproic Acid—epilepsy syndrome	6.34e-05	0.000174	CcSEcCtD
Darunavir—Palpitations—Gabapentin—epilepsy syndrome	6.33e-05	0.000174	CcSEcCtD
Darunavir—Dermatitis—Zonisamide—epilepsy syndrome	6.33e-05	0.000174	CcSEcCtD
Darunavir—Dizziness—Oxcarbazepine—epilepsy syndrome	6.33e-05	0.000174	CcSEcCtD
Darunavir—Nausea—Diazepam—epilepsy syndrome	6.3e-05	0.000173	CcSEcCtD
Darunavir—Loss of consciousness—Gabapentin—epilepsy syndrome	6.3e-05	0.000173	CcSEcCtD
Darunavir—Headache—Zonisamide—epilepsy syndrome	6.3e-05	0.000173	CcSEcCtD
Darunavir—Dyspnoea—Valproic Acid—epilepsy syndrome	6.29e-05	0.000173	CcSEcCtD
Darunavir—Diarrhoea—Carbamazepine—epilepsy syndrome	6.29e-05	0.000172	CcSEcCtD
Darunavir—Angiopathy—Topiramate—epilepsy syndrome	6.28e-05	0.000172	CcSEcCtD
Darunavir—Pruritus—Lamotrigine—epilepsy syndrome	6.28e-05	0.000172	CcSEcCtD
Darunavir—Shock—Pregabalin—epilepsy syndrome	6.28e-05	0.000172	CcSEcCtD
Darunavir—Somnolence—Valproic Acid—epilepsy syndrome	6.27e-05	0.000172	CcSEcCtD
Darunavir—Immune system disorder—Topiramate—epilepsy syndrome	6.26e-05	0.000172	CcSEcCtD
Darunavir—Nervous system disorder—Pregabalin—epilepsy syndrome	6.26e-05	0.000172	CcSEcCtD
Darunavir—Cough—Gabapentin—epilepsy syndrome	6.25e-05	0.000172	CcSEcCtD
Darunavir—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.25e-05	0.000171	CcSEcCtD
Darunavir—Mediastinal disorder—Topiramate—epilepsy syndrome	6.24e-05	0.000171	CcSEcCtD
Darunavir—Tachycardia—Pregabalin—epilepsy syndrome	6.23e-05	0.000171	CcSEcCtD
Darunavir—Chills—Topiramate—epilepsy syndrome	6.22e-05	0.000171	CcSEcCtD
Darunavir—Dyspepsia—Valproic Acid—epilepsy syndrome	6.21e-05	0.00017	CcSEcCtD
Darunavir—Convulsion—Gabapentin—epilepsy syndrome	6.21e-05	0.00017	CcSEcCtD
Darunavir—Skin disorder—Pregabalin—epilepsy syndrome	6.2e-05	0.00017	CcSEcCtD
Darunavir—Hypertension—Gabapentin—epilepsy syndrome	6.19e-05	0.00017	CcSEcCtD
Darunavir—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.17e-05	0.000169	CcSEcCtD
Darunavir—Vomiting—Clonazepam—epilepsy syndrome	6.16e-05	0.000169	CcSEcCtD
Darunavir—Decreased appetite—Valproic Acid—epilepsy syndrome	6.13e-05	0.000168	CcSEcCtD
Darunavir—Alopecia—Topiramate—epilepsy syndrome	6.12e-05	0.000168	CcSEcCtD
Darunavir—Vomiting—Phenytoin—epilepsy syndrome	6.12e-05	0.000168	CcSEcCtD
Darunavir—Rash—Clonazepam—epilepsy syndrome	6.11e-05	0.000168	CcSEcCtD
Darunavir—Dermatitis—Clonazepam—epilepsy syndrome	6.1e-05	0.000167	CcSEcCtD
Darunavir—Arthralgia—Gabapentin—epilepsy syndrome	6.1e-05	0.000167	CcSEcCtD
Darunavir—Myalgia—Gabapentin—epilepsy syndrome	6.1e-05	0.000167	CcSEcCtD
Darunavir—Chest pain—Gabapentin—epilepsy syndrome	6.1e-05	0.000167	CcSEcCtD
Darunavir—Nausea—Felbamate—epilepsy syndrome	6.1e-05	0.000167	CcSEcCtD
Darunavir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	6.09e-05	0.000167	CcSEcCtD
Darunavir—Vomiting—Oxcarbazepine—epilepsy syndrome	6.09e-05	0.000167	CcSEcCtD
Darunavir—Fatigue—Valproic Acid—epilepsy syndrome	6.08e-05	0.000167	CcSEcCtD
Darunavir—Anxiety—Gabapentin—epilepsy syndrome	6.08e-05	0.000167	CcSEcCtD
Darunavir—Anorexia—Pregabalin—epilepsy syndrome	6.08e-05	0.000167	CcSEcCtD
Darunavir—Dizziness—Carbamazepine—epilepsy syndrome	6.08e-05	0.000167	CcSEcCtD
Darunavir—Diarrhoea—Lamotrigine—epilepsy syndrome	6.08e-05	0.000167	CcSEcCtD
Darunavir—Headache—Clonazepam—epilepsy syndrome	6.07e-05	0.000167	CcSEcCtD
Darunavir—Rash—Phenytoin—epilepsy syndrome	6.07e-05	0.000167	CcSEcCtD
Darunavir—Mental disorder—Topiramate—epilepsy syndrome	6.07e-05	0.000166	CcSEcCtD
Darunavir—Dermatitis—Phenytoin—epilepsy syndrome	6.06e-05	0.000166	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	6.06e-05	0.000166	CcSEcCtD
Darunavir—Rash—Oxcarbazepine—epilepsy syndrome	6.04e-05	0.000166	CcSEcCtD
Darunavir—Constipation—Valproic Acid—epilepsy syndrome	6.03e-05	0.000166	CcSEcCtD
Darunavir—Pain—Valproic Acid—epilepsy syndrome	6.03e-05	0.000166	CcSEcCtD
Darunavir—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.03e-05	0.000165	CcSEcCtD
Darunavir—Headache—Phenytoin—epilepsy syndrome	6.03e-05	0.000165	CcSEcCtD
Darunavir—Malnutrition—Topiramate—epilepsy syndrome	6.03e-05	0.000165	CcSEcCtD
Darunavir—Erythema—Topiramate—epilepsy syndrome	6.03e-05	0.000165	CcSEcCtD
Darunavir—Discomfort—Gabapentin—epilepsy syndrome	6.03e-05	0.000165	CcSEcCtD
Darunavir—Headache—Oxcarbazepine—epilepsy syndrome	6e-05	0.000165	CcSEcCtD
Darunavir—Nausea—Zonisamide—epilepsy syndrome	5.97e-05	0.000164	CcSEcCtD
Darunavir—Dry mouth—Gabapentin—epilepsy syndrome	5.97e-05	0.000164	CcSEcCtD
Darunavir—Flatulence—Topiramate—epilepsy syndrome	5.94e-05	0.000163	CcSEcCtD
Darunavir—Dysgeusia—Topiramate—epilepsy syndrome	5.91e-05	0.000162	CcSEcCtD
Darunavir—Confusional state—Gabapentin—epilepsy syndrome	5.9e-05	0.000162	CcSEcCtD
Darunavir—Dizziness—Lamotrigine—epilepsy syndrome	5.87e-05	0.000161	CcSEcCtD
Darunavir—Vomiting—Carbamazepine—epilepsy syndrome	5.84e-05	0.00016	CcSEcCtD
Darunavir—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.81e-05	0.00016	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.81e-05	0.000159	CcSEcCtD
Darunavir—Muscle spasms—Topiramate—epilepsy syndrome	5.8e-05	0.000159	CcSEcCtD
Darunavir—Rash—Carbamazepine—epilepsy syndrome	5.79e-05	0.000159	CcSEcCtD
Darunavir—Dermatitis—Carbamazepine—epilepsy syndrome	5.79e-05	0.000159	CcSEcCtD
Darunavir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.77e-05	0.000158	CcSEcCtD
Darunavir—Insomnia—Pregabalin—epilepsy syndrome	5.77e-05	0.000158	CcSEcCtD
Darunavir—Nausea—Clonazepam—epilepsy syndrome	5.76e-05	0.000158	CcSEcCtD
Darunavir—Headache—Carbamazepine—epilepsy syndrome	5.76e-05	0.000158	CcSEcCtD
Darunavir—Shock—Gabapentin—epilepsy syndrome	5.76e-05	0.000158	CcSEcCtD
Darunavir—Nervous system disorder—Gabapentin—epilepsy syndrome	5.74e-05	0.000157	CcSEcCtD
Darunavir—Paraesthesia—Pregabalin—epilepsy syndrome	5.73e-05	0.000157	CcSEcCtD
Darunavir—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.73e-05	0.000157	CcSEcCtD
Darunavir—Nausea—Phenytoin—epilepsy syndrome	5.72e-05	0.000157	CcSEcCtD
Darunavir—Tachycardia—Gabapentin—epilepsy syndrome	5.71e-05	0.000157	CcSEcCtD
Darunavir—Dyspnoea—Pregabalin—epilepsy syndrome	5.69e-05	0.000156	CcSEcCtD
Darunavir—Nausea—Oxcarbazepine—epilepsy syndrome	5.69e-05	0.000156	CcSEcCtD
Darunavir—Skin disorder—Gabapentin—epilepsy syndrome	5.68e-05	0.000156	CcSEcCtD
Darunavir—Somnolence—Pregabalin—epilepsy syndrome	5.67e-05	0.000156	CcSEcCtD
Darunavir—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.66e-05	0.000155	CcSEcCtD
Darunavir—Vomiting—Lamotrigine—epilepsy syndrome	5.65e-05	0.000155	CcSEcCtD
Darunavir—Urticaria—Valproic Acid—epilepsy syndrome	5.61e-05	0.000154	CcSEcCtD
Darunavir—Rash—Lamotrigine—epilepsy syndrome	5.6e-05	0.000154	CcSEcCtD
Darunavir—Ill-defined disorder—Topiramate—epilepsy syndrome	5.6e-05	0.000153	CcSEcCtD
Darunavir—Dermatitis—Lamotrigine—epilepsy syndrome	5.59e-05	0.000153	CcSEcCtD
Darunavir—Abdominal pain—Valproic Acid—epilepsy syndrome	5.58e-05	0.000153	CcSEcCtD
Darunavir—Body temperature increased—Valproic Acid—epilepsy syndrome	5.58e-05	0.000153	CcSEcCtD
Darunavir—Anorexia—Gabapentin—epilepsy syndrome	5.58e-05	0.000153	CcSEcCtD
Darunavir—Anaemia—Topiramate—epilepsy syndrome	5.57e-05	0.000153	CcSEcCtD
Darunavir—Headache—Lamotrigine—epilepsy syndrome	5.56e-05	0.000153	CcSEcCtD
Darunavir—Decreased appetite—Pregabalin—epilepsy syndrome	5.55e-05	0.000152	CcSEcCtD
Darunavir—Agitation—Topiramate—epilepsy syndrome	5.54e-05	0.000152	CcSEcCtD
Darunavir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.51e-05	0.000151	CcSEcCtD
Darunavir—Fatigue—Pregabalin—epilepsy syndrome	5.5e-05	0.000151	CcSEcCtD
Darunavir—Nausea—Carbamazepine—epilepsy syndrome	5.46e-05	0.00015	CcSEcCtD
Darunavir—Pain—Pregabalin—epilepsy syndrome	5.46e-05	0.00015	CcSEcCtD
Darunavir—Constipation—Pregabalin—epilepsy syndrome	5.46e-05	0.00015	CcSEcCtD
Darunavir—Malaise—Topiramate—epilepsy syndrome	5.44e-05	0.000149	CcSEcCtD
Darunavir—Vertigo—Topiramate—epilepsy syndrome	5.42e-05	0.000149	CcSEcCtD
Darunavir—Syncope—Topiramate—epilepsy syndrome	5.41e-05	0.000148	CcSEcCtD
Darunavir—Leukopenia—Topiramate—epilepsy syndrome	5.4e-05	0.000148	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.33e-05	0.000146	CcSEcCtD
Darunavir—Palpitations—Topiramate—epilepsy syndrome	5.33e-05	0.000146	CcSEcCtD
Darunavir—Loss of consciousness—Topiramate—epilepsy syndrome	5.3e-05	0.000145	CcSEcCtD
Darunavir—Insomnia—Gabapentin—epilepsy syndrome	5.29e-05	0.000145	CcSEcCtD
Darunavir—Nausea—Lamotrigine—epilepsy syndrome	5.27e-05	0.000145	CcSEcCtD
Darunavir—Cough—Topiramate—epilepsy syndrome	5.26e-05	0.000144	CcSEcCtD
Darunavir—Feeling abnormal—Pregabalin—epilepsy syndrome	5.26e-05	0.000144	CcSEcCtD
Darunavir—Paraesthesia—Gabapentin—epilepsy syndrome	5.25e-05	0.000144	CcSEcCtD
Darunavir—Convulsion—Topiramate—epilepsy syndrome	5.22e-05	0.000143	CcSEcCtD
Darunavir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.22e-05	0.000143	CcSEcCtD
Darunavir—Dyspnoea—Gabapentin—epilepsy syndrome	5.22e-05	0.000143	CcSEcCtD
Darunavir—Hypertension—Topiramate—epilepsy syndrome	5.21e-05	0.000143	CcSEcCtD
Darunavir—Somnolence—Gabapentin—epilepsy syndrome	5.2e-05	0.000143	CcSEcCtD
Darunavir—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.2e-05	0.000143	CcSEcCtD
Darunavir—Dyspepsia—Gabapentin—epilepsy syndrome	5.15e-05	0.000141	CcSEcCtD
Darunavir—Arthralgia—Topiramate—epilepsy syndrome	5.13e-05	0.000141	CcSEcCtD
Darunavir—Chest pain—Topiramate—epilepsy syndrome	5.13e-05	0.000141	CcSEcCtD
Darunavir—Myalgia—Topiramate—epilepsy syndrome	5.13e-05	0.000141	CcSEcCtD
Darunavir—Anxiety—Topiramate—epilepsy syndrome	5.12e-05	0.00014	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.1e-05	0.00014	CcSEcCtD
Darunavir—Decreased appetite—Gabapentin—epilepsy syndrome	5.09e-05	0.00014	CcSEcCtD
Darunavir—Discomfort—Topiramate—epilepsy syndrome	5.07e-05	0.000139	CcSEcCtD
Darunavir—Urticaria—Pregabalin—epilepsy syndrome	5.07e-05	0.000139	CcSEcCtD
Darunavir—Asthenia—Valproic Acid—epilepsy syndrome	5.06e-05	0.000139	CcSEcCtD
Darunavir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.05e-05	0.000139	CcSEcCtD
Darunavir—Fatigue—Gabapentin—epilepsy syndrome	5.04e-05	0.000138	CcSEcCtD
Darunavir—Abdominal pain—Pregabalin—epilepsy syndrome	5.04e-05	0.000138	CcSEcCtD
Darunavir—Body temperature increased—Pregabalin—epilepsy syndrome	5.04e-05	0.000138	CcSEcCtD
Darunavir—Dry mouth—Topiramate—epilepsy syndrome	5.02e-05	0.000138	CcSEcCtD
Darunavir—Constipation—Gabapentin—epilepsy syndrome	5e-05	0.000137	CcSEcCtD
Darunavir—Pain—Gabapentin—epilepsy syndrome	5e-05	0.000137	CcSEcCtD
Darunavir—Pruritus—Valproic Acid—epilepsy syndrome	4.99e-05	0.000137	CcSEcCtD
Darunavir—Confusional state—Topiramate—epilepsy syndrome	4.96e-05	0.000136	CcSEcCtD
Darunavir—Shock—Topiramate—epilepsy syndrome	4.84e-05	0.000133	CcSEcCtD
Darunavir—Diarrhoea—Valproic Acid—epilepsy syndrome	4.83e-05	0.000132	CcSEcCtD
Darunavir—Nervous system disorder—Topiramate—epilepsy syndrome	4.83e-05	0.000132	CcSEcCtD
Darunavir—Feeling abnormal—Gabapentin—epilepsy syndrome	4.82e-05	0.000132	CcSEcCtD
Darunavir—Thrombocytopenia—Topiramate—epilepsy syndrome	4.82e-05	0.000132	CcSEcCtD
Darunavir—Tachycardia—Topiramate—epilepsy syndrome	4.8e-05	0.000132	CcSEcCtD
Darunavir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.78e-05	0.000131	CcSEcCtD
Darunavir—Skin disorder—Topiramate—epilepsy syndrome	4.78e-05	0.000131	CcSEcCtD
Darunavir—Hyperhidrosis—Topiramate—epilepsy syndrome	4.76e-05	0.000131	CcSEcCtD
Darunavir—Hypersensitivity—Pregabalin—epilepsy syndrome	4.7e-05	0.000129	CcSEcCtD
Darunavir—Anorexia—Topiramate—epilepsy syndrome	4.69e-05	0.000129	CcSEcCtD
Darunavir—Dizziness—Valproic Acid—epilepsy syndrome	4.67e-05	0.000128	CcSEcCtD
Darunavir—Urticaria—Gabapentin—epilepsy syndrome	4.65e-05	0.000127	CcSEcCtD
Darunavir—Abdominal pain—Gabapentin—epilepsy syndrome	4.62e-05	0.000127	CcSEcCtD
Darunavir—Body temperature increased—Gabapentin—epilepsy syndrome	4.62e-05	0.000127	CcSEcCtD
Darunavir—Asthenia—Pregabalin—epilepsy syndrome	4.58e-05	0.000126	CcSEcCtD
Darunavir—Pruritus—Pregabalin—epilepsy syndrome	4.51e-05	0.000124	CcSEcCtD
Darunavir—Vomiting—Valproic Acid—epilepsy syndrome	4.49e-05	0.000123	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.48e-05	0.000123	CcSEcCtD
Darunavir—Insomnia—Topiramate—epilepsy syndrome	4.45e-05	0.000122	CcSEcCtD
Darunavir—Rash—Valproic Acid—epilepsy syndrome	4.45e-05	0.000122	CcSEcCtD
Darunavir—Dermatitis—Valproic Acid—epilepsy syndrome	4.45e-05	0.000122	CcSEcCtD
Darunavir—Headache—Valproic Acid—epilepsy syndrome	4.42e-05	0.000121	CcSEcCtD
Darunavir—Paraesthesia—Topiramate—epilepsy syndrome	4.42e-05	0.000121	CcSEcCtD
Darunavir—Dyspnoea—Topiramate—epilepsy syndrome	4.39e-05	0.00012	CcSEcCtD
Darunavir—Somnolence—Topiramate—epilepsy syndrome	4.38e-05	0.00012	CcSEcCtD
Darunavir—Diarrhoea—Pregabalin—epilepsy syndrome	4.36e-05	0.00012	CcSEcCtD
Darunavir—Dyspepsia—Topiramate—epilepsy syndrome	4.33e-05	0.000119	CcSEcCtD
Darunavir—Hypersensitivity—Gabapentin—epilepsy syndrome	4.31e-05	0.000118	CcSEcCtD
Darunavir—Decreased appetite—Topiramate—epilepsy syndrome	4.28e-05	0.000117	CcSEcCtD
Darunavir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.25e-05	0.000117	CcSEcCtD
Darunavir—Fatigue—Topiramate—epilepsy syndrome	4.24e-05	0.000116	CcSEcCtD
Darunavir—Dizziness—Pregabalin—epilepsy syndrome	4.22e-05	0.000116	CcSEcCtD
Darunavir—Pain—Topiramate—epilepsy syndrome	4.21e-05	0.000115	CcSEcCtD
Darunavir—Constipation—Topiramate—epilepsy syndrome	4.21e-05	0.000115	CcSEcCtD
Darunavir—Asthenia—Gabapentin—epilepsy syndrome	4.2e-05	0.000115	CcSEcCtD
Darunavir—Nausea—Valproic Acid—epilepsy syndrome	4.19e-05	0.000115	CcSEcCtD
Darunavir—Pruritus—Gabapentin—epilepsy syndrome	4.14e-05	0.000114	CcSEcCtD
Darunavir—Vomiting—Pregabalin—epilepsy syndrome	4.06e-05	0.000111	CcSEcCtD
Darunavir—Feeling abnormal—Topiramate—epilepsy syndrome	4.06e-05	0.000111	CcSEcCtD
Darunavir—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.02e-05	0.00011	CcSEcCtD
Darunavir—Rash—Pregabalin—epilepsy syndrome	4.02e-05	0.00011	CcSEcCtD
Darunavir—Dermatitis—Pregabalin—epilepsy syndrome	4.02e-05	0.00011	CcSEcCtD
Darunavir—Diarrhoea—Gabapentin—epilepsy syndrome	4e-05	0.00011	CcSEcCtD
Darunavir—Headache—Pregabalin—epilepsy syndrome	4e-05	0.00011	CcSEcCtD
Darunavir—Urticaria—Topiramate—epilepsy syndrome	3.91e-05	0.000107	CcSEcCtD
Darunavir—Abdominal pain—Topiramate—epilepsy syndrome	3.89e-05	0.000107	CcSEcCtD
Darunavir—Body temperature increased—Topiramate—epilepsy syndrome	3.89e-05	0.000107	CcSEcCtD
Darunavir—Dizziness—Gabapentin—epilepsy syndrome	3.87e-05	0.000106	CcSEcCtD
Darunavir—Nausea—Pregabalin—epilepsy syndrome	3.79e-05	0.000104	CcSEcCtD
Darunavir—Vomiting—Gabapentin—epilepsy syndrome	3.72e-05	0.000102	CcSEcCtD
Darunavir—Rash—Gabapentin—epilepsy syndrome	3.69e-05	0.000101	CcSEcCtD
Darunavir—Dermatitis—Gabapentin—epilepsy syndrome	3.69e-05	0.000101	CcSEcCtD
Darunavir—Headache—Gabapentin—epilepsy syndrome	3.66e-05	0.000101	CcSEcCtD
Darunavir—Hypersensitivity—Topiramate—epilepsy syndrome	3.63e-05	9.95e-05	CcSEcCtD
Darunavir—Asthenia—Topiramate—epilepsy syndrome	3.53e-05	9.69e-05	CcSEcCtD
Darunavir—Pruritus—Topiramate—epilepsy syndrome	3.48e-05	9.55e-05	CcSEcCtD
Darunavir—Nausea—Gabapentin—epilepsy syndrome	3.47e-05	9.53e-05	CcSEcCtD
Darunavir—Diarrhoea—Topiramate—epilepsy syndrome	3.37e-05	9.24e-05	CcSEcCtD
Darunavir—Dizziness—Topiramate—epilepsy syndrome	3.25e-05	8.93e-05	CcSEcCtD
Darunavir—Vomiting—Topiramate—epilepsy syndrome	3.13e-05	8.58e-05	CcSEcCtD
Darunavir—Rash—Topiramate—epilepsy syndrome	3.1e-05	8.51e-05	CcSEcCtD
Darunavir—Dermatitis—Topiramate—epilepsy syndrome	3.1e-05	8.51e-05	CcSEcCtD
Darunavir—Headache—Topiramate—epilepsy syndrome	3.08e-05	8.46e-05	CcSEcCtD
Darunavir—Nausea—Topiramate—epilepsy syndrome	2.92e-05	8.02e-05	CcSEcCtD
